Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00108264 · ClinicalTrials.gov registry record · Phase 1
Tumor RNA Transfected Dendritic Cell Vaccines
A Phase 1 study, sponsored by US Department of Veterans Affairs.
- Completed
- Registry status
- Phase 1
- Development phase
NCT00108264 is a Phase 1 study that has completed, run by US Department of Veterans Affairs.
The verdict
NCT00108264, a Phase 1 study, has completed, sponsored by US Department of Veterans Affairs.
- COMPLETED
- Registry status
- Phase 1
- Development phase
Study Summary
The purpose of this study is to use dendritic cells transfected with amplified RNA from autologous tumor cells to develop a vaccine strategy for the treatment of prostate cancer in patients with disseminated disease.
Interventions
- BIOLOGICAL Tumor RNA transfected dendritic cells
Trial Details
| Field | Value |
|---|---|
| Est. Completion | 2005-09 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00108264
The ClinicalTrials.gov registry entry for NCT00108264 describes a study currently listed as completed, categorized as Phase 1. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is US Department of Veterans Affairs, which has 632 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Tumor RNA transfected dendritic cells is the first listed.
NCT00108264 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00108264 about?
NCT00108264 is a clinical study titled "Tumor RNA Transfected Dendritic Cell Vaccines". The purpose of this study is to use dendritic cells transfected with amplified RNA from autologous tumor cells to develop a vaccine strategy for the treatment of prostate cancer in patients with disseminated disease.
What is the current status of trial NCT00108264?
This trial is currently completed. It is a Phase 1 study. Estimated completion is 2005-09.
What interventions are being tested in trial NCT00108264?
The interventions under investigation include: Tumor RNA transfected dendritic cells (BIOLOGICAL).
Who is sponsoring clinical trial NCT00108264?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.